Orchard Therapeutics to Present at the Cowen 39th Annual Health Care Conference on March 11, 2019
A live webcast of the presentation will be available under "News & Events" in the Investors & Media section of the company's website at orchard-tx.com. A replay of the webcast will be archived on the Orchard website following the presentation.
About Orchard
Orchard’s portfolio of autologous, ex vivo, hematopoietic stem cell gene therapies includes Strimvelis, the first such treatment approved by the
Orchard currently has offices in the
Contacts
Corporate & Investor contact
Director, Investor Relations
+1 862-242-0764
Renee.Leck@orchard-tx.com
Media contact
LifeSci Public Relations
+1 516-655-0842
Allison@lifescipublicrelations.com
Source: Orchard Therapeutics Limited